Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study
Autor: | F. T. Ageev, M. D. Smirnova |
---|---|
Jazyk: | English<br />Russian |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 638-647 (2023) |
Druh dokumentu: | article |
ISSN: | 1819-6446 2225-3653 |
DOI: | 10.20996/1819-6446-2022-12-01 |
Popis: | Aim. To assess the clinical outcomes and tolerability of antihypertensive therapy with single pill combinations (SPC) amlodipine + telmisartan and hydrochlorothiazide + telmisartan in clinical practice.Material and methods. Patients with hypertension of grade 1-3 (n=13647; 57.6% women; age 59.3±11.4 years) who received therapy with SPC amlodipine + telmisartan or hydrochlorothiazide + telmisartan were included in an observational multicenter study. Information on complaints, history, previous therapy, history of novel coronavirus infection (COVID-19) during the previous year was obtained. Also, measurement of height, body weight, waist circumference (WC) and hips (HC), office blood pressure (BP) three times with an interval of 4 weeks, completion of questionnaires of satisfaction with therapy using the Likert scale, and assessement of adherence to therapy according to the patient's opinion was performed.Results. A statistically significant decrease in systolic (SBP) and diastolic blood pressure (DBP) was found both in all patients and in the analysis of subgroups according to the grade of hypertension (p |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |